Literature DB >> 11967069

Candida albicans Als1p: an adhesin that is a downstream effector of the EFG1 filamentation pathway.

Yue Fu1, Ashraf S Ibrahim, Donald C Sheppard, Yee-Chun Chen, Samuel W French, Jim E Cutler, Scott G Filler, John E Edwards.   

Abstract

Filamentation and adherence to host cells are critical virulence factors of Candida albicans. Multiple filamentation regulatory pathways have been discovered in C. albicans using Saccharomyces cerevisiae as a model. In S. cerevisiae, these pathways converge on Flo11p, which functions as a downstream effector of filamentation and also mediates cell-cell adherence (flocculation). In C. albicans, such effector(s) have not yet been identified. Here, we demonstrate that the cell surface protein Als1p is an effector of filamentation in C. albicans. We show that Als1p expression is controlled by the transcription factor Efg1p, which is known to be a key regulator of filamentation in C. albicans. Further, disruption of ALS1 inhibited filamentation, and autonomous expression of Als1p restored filamentation in an efg1 homozygous null mutant. Thus, Als1p functions as a downstream effector of the EFG1 filamentation pathway. In addition, we found that Als1p mediates both flocculation and adherence of C. albicans to endothelial cells in vitro. As a cell surface glycoprotein that mediates filamentation and adherence, Als1p has both structural and functional similarity to S. cerevisiae Flo11p. Consistent with our in vitro results, Als1p was required for both normal filamentation and virulence in the mouse model of haematogenously disseminated candidiasis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11967069     DOI: 10.1046/j.1365-2958.2002.02873.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  108 in total

1.  E1210, a new broad-spectrum antifungal, suppresses Candida albicans hyphal growth through inhibition of glycosylphosphatidylinositol biosynthesis.

Authors:  Nao-Aki Watanabe; Mamiko Miyazaki; Takaaki Horii; Koji Sagane; Kappei Tsukahara; Katsura Hata
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  C. albicans increases cell wall mannoprotein, but not mannan, in response to blood, serum and cultivation at physiological temperature.

Authors:  Michael Kruppa; Rachel R Greene; Ilka Noss; Douglas W Lowman; David L Williams
Journal:  Glycobiology       Date:  2011-04-21       Impact factor: 4.313

3.  Contribution of Candida albicans ALS1 to the pathogenesis of experimental oropharyngeal candidiasis.

Authors:  Yasuki Kamai; Mikie Kubota; Yoko Kamai; Tsunemichi Hosokawa; Takashi Fukuoka; Scott G Filler
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

4.  Roles of Candida albicans Dfg5p and Dcw1p cell surface proteins in growth and hypha formation.

Authors:  Elisabetta Spreghini; Dana A Davis; Ryan Subaran; Michelle Kim; Aaron P Mitchell
Journal:  Eukaryot Cell       Date:  2003-08

5.  APSES proteins regulate morphogenesis and metabolism in Candida albicans.

Authors:  Thomas Doedt; Shankarling Krishnamurthy; Dirk P Bockmühl; Bernd Tebarth; Christian Stempel; Claire L Russell; Alistair J P Brown; Joachim F Ernst
Journal:  Mol Biol Cell       Date:  2004-07       Impact factor: 4.138

6.  Transcription factor Efg1 shows a haploinsufficiency phenotype in modulating the cell wall architecture and immunogenicity of Candida albicans.

Authors:  Martin Zavrel; Olivia Majer; Karl Kuchler; Steffen Rupp
Journal:  Eukaryot Cell       Date:  2011-12-02

Review 7.  An insight into the antifungal pipeline: selected new molecules and beyond.

Authors:  Luis Ostrosky-Zeichner; Arturo Casadevall; John N Galgiani; Frank C Odds; John H Rex
Journal:  Nat Rev Drug Discov       Date:  2010-08-20       Impact factor: 84.694

8.  The anti-Candida albicans vaccine composed of the recombinant N terminus of Als1p reduces fungal burden and improves survival in both immunocompetent and immunocompromised mice.

Authors:  Brad J Spellberg; Ashraf S Ibrahim; Valentina Avenissian; Scott G Filler; Carter L Myers; Yue Fu; John E Edwards
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 9.  Comprehensive analysis of glycosylphosphatidylinositol-anchored proteins in Candida albicans.

Authors:  Mathias L Richard; Armêl Plaine
Journal:  Eukaryot Cell       Date:  2006-12-22

10.  A genome-wide steroid response study of the major human fungal pathogen Candida albicans.

Authors:  Dibyendu Banerjee; Nuria Martin; Soumyadeep Nandi; Sudhanshu Shukla; Angel Dominguez; Gauranga Mukhopadhyay; Rajendra Prasad
Journal:  Mycopathologia       Date:  2007-06-16       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.